TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2008

Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.

Borje S Andersson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.